Deutsche Bank began coverage on shares of Cardinal Health (NYSE:CAH) in a report released on Thursday, BenzingaRatingsTable reports. The firm issued a hold rating and a $50.00 price objective on the stock.
Several other equities research analysts also recently issued reports on CAH. Argus downgraded Cardinal Health from a buy rating to a hold rating in a research report on Tuesday, August 27th. Morgan Stanley dropped their target price on Cardinal Health from $50.00 to $41.00 and set an underweight rating on the stock in a research report on Friday, September 6th. Finally, Guggenheim upgraded Cardinal Health from a neutral rating to a buy rating and increased their target price for the stock from $50.00 to $52.00 in a research report on Tuesday, August 20th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company. The stock has a consensus rating of Hold and an average price target of $53.25.
Cardinal Health stock traded down $0.29 during trading on Thursday, hitting $48.19. The stock had a trading volume of 103,893 shares, compared to its average volume of 2,683,163. Cardinal Health has a 1 year low of $41.03 and a 1 year high of $58.31. The company has a quick ratio of 0.54, a current ratio of 1.07 and a debt-to-equity ratio of 1.20. The stock’s 50 day moving average is $44.33 and its two-hundred day moving average is $46.49. The stock has a market cap of $14.43 billion, a price-to-earnings ratio of 9.10, a price-to-earnings-growth ratio of 1.59 and a beta of 1.29.
Several large investors have recently bought and sold shares of CAH. Vanguard Group Inc. increased its holdings in shares of Cardinal Health by 1.8% in the second quarter. Vanguard Group Inc. now owns 35,800,690 shares of the company’s stock worth $1,686,212,000 after purchasing an additional 622,563 shares during the period. Invesco Ltd. increased its holdings in shares of Cardinal Health by 28.5% in the second quarter. Invesco Ltd. now owns 8,150,786 shares of the company’s stock worth $383,901,000 after purchasing an additional 1,808,381 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in shares of Cardinal Health by 5.5% in the second quarter. Price T Rowe Associates Inc. MD now owns 4,205,388 shares of the company’s stock worth $198,074,000 after purchasing an additional 217,385 shares during the period. Geode Capital Management LLC increased its holdings in shares of Cardinal Health by 5.4% in the fourth quarter. Geode Capital Management LLC now owns 4,155,931 shares of the company’s stock worth $185,121,000 after purchasing an additional 213,970 shares during the period. Finally, Northern Trust Corp increased its holdings in shares of Cardinal Health by 5.3% in the first quarter. Northern Trust Corp now owns 4,029,570 shares of the company’s stock worth $194,024,000 after purchasing an additional 203,897 shares during the period. Hedge funds and other institutional investors own 88.57% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Featured Story: What are the benefits of investing in REITs?
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.